Evidence map›Paper›PMID 25027852›Full record

ArticleNature communications2014

Identification of platelet function defects by multi-parameter assessment of thrombus formation.

Susanne M de Witt, Frauke Swieringa, Rachel Cavill, Moniek M E Lamers, Roger van Kruchten, Tom Mastenbroek, Constance Baaten, Susan Coort, Nicholas Pugh, Ansgar Schulz and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 1 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 1 synthesis or guideline pooled it, 235 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Susanne M de WittDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Frauke Swieringa1] Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands [2].
Rachel Cavill1] Department of Toxicogenomics, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands [2].
Moniek M E LamersDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Roger van KruchtenDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Tom MastenbroekDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Constance BaatenDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Susan CoortDepartment of Bioinformatics, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Nicholas PughAnglia Ruskin University, East Rd, Cambridge CB11PT, UK.
Ansgar SchulzPediatric Centre, University Clinic Ulm, Universitätsklinik Für Kinder- und Jugendmedizin, Eythstrasse 24, D-89075 Ulm, Germany.
Inge ScharrerCenter for Thrombosis and Haemostasis (CTH), Universitätsmedizin der Johannes Gutenberg, University of Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany.
Kerstin JurkCenter for Thrombosis and Haemostasis (CTH), Universitätsmedizin der Johannes Gutenberg, University of Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany.
Barbara ZiegerDepartment of Pediatrics and Adolescent Medicine, University Medical Centre Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany.
Kenneth J ClemetsonDepartment of Haematology, Inselspital, University of Bern, CH-3010 Bern, Switzerland.
Richard W FarndaleDepartment of Biochemistry, University of Cambridge, Downing Site, Cambridge CB2 1QW, UK.
Johan W M Heemskerk1] Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands [2].
Judith M E M Cosemans1] Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands [2].
Maastricht University · NLAnglia Ruskin University · GBUniversity of Bern · CHUniversity of Cambridge · GB

Funding

British Heart Foundation RG/09/003/27122Wellcome Trust 094470/Z/10/Z
6 · The paper itself

Abstract

Assays measuring platelet aggregation (thrombus formation) at arterial shear rate mostly use collagen as only platelet-adhesive surface. Here we report a multi-surface and multi-parameter flow assay to characterize thrombus formation in whole blood from healthy subjects and patients with platelet function deficiencies. A systematic comparison is made of 52 adhesive surfaces with components activating the main platelet-adhesive receptors, and of eight output parameters reflecting distinct stages of thrombus formation. Three types of thrombus formation can be identified with a predicted hierarchy of the following receptors: glycoprotein (GP)VI, C-type lectin-like receptor-2 (CLEC-2)>GPIb>α6β1, αIIbβ3>α2β1>CD36, α5β1, αvβ3. Application with patient blood reveals distinct abnormalities in thrombus formation in patients with severe combined immune deficiency, Glanzmann's thrombasthenia, Hermansky-Pudlak syndrome, May-Hegglin anomaly or grey platelet syndrome. We suggest this test may be useful for the diagnosis of patients with suspected bleeding disorders or a pro-thrombotic tendency.

Indexed as

AdultBiological AssayComputational BiologyFemaleHumansMaleMiddle AgedPlatelet AggregationThrombosisYoung Adult

Identifiers

PMID25027852
PMCPMC4109023
OpenAlexW2041777103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.